VillageMD has turned out to be a challenging venture for Walgreens, which invested $5.2 billion in 2021 to take a majority ...

Walgreens reported a loss of $2.85 billion in its fiscal second quarter, pulled down by a hefty impairment charge related to ...

Walgreens Boots Alliance Inc. shares ended Tuesday’s session down 1.1% after the drugstore chain reported ...

Walgreens also withdrew its 2025 financial guidance, citing the pending take-private deal, which is expected to close by the ...

The drugstore chain booked pharmacy sales gains, and its struggling VillageMD clinic business delivered a smaller balance ...

Walgreens Boots Alliance reported quarterly profit that exceeded Wall Street’s expectations, marking a strong performance in ...

Drug store chain reports revenue and adjusted earnings that topped estimates as it prepares to be taken private ...

Walgreens delivered a better-than-expected fiscal second quarter and smaller loss a month after announcing that it would be ...

Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced financial results for the second quarter of fiscal 2025, which ended February 28, 2025.

The drugstore chain booked pharmacy sales gains, and its struggling VillageMD clinic business delivered a smaller balance sheet hit in the recently concluded quarter. Overall, Walgreens said ...

Healthcare-segment sales were $2.152 billion, down from $2.176 billion in the same period last year, which the company attributed to lower fee-for-service and risk-based revenue at VillageMD ...